Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony stimulating factor (GM-CSF): II. Adverse effects of GM-CSF
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F12%3A13588" target="_blank" >RIV/00216208:11110/12:13588 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/12:43901004 RIV/00064173:_____/12:43901004 RIV/00023736:_____/12:00010573 RIV/00064165:_____/12:13588
Result on the web
<a href="http://dx.doi.org/10.3892/ijo.2012.1410" target="_blank" >http://dx.doi.org/10.3892/ijo.2012.1410</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony stimulating factor (GM-CSF): II. Adverse effects of GM-CSF
Original language description
Granulocyte-macrophage colony stimulating factor (GM-CSF) is considered to be the most effective immunostimulating factor for the construction of gene-engineered anti-cancer vaccines. In some tumour cells, this type of genetic modification has resulted in the loss of the oncogenic potential. This was not the case with bcr-abl-transformed mouse 12B1 cells. A cell line, designated 12B1/GM-CSF/cl-5 producing more than 100 ng/10(6) cells/24 h, displayed higher pathogenicity than the parental, non-transducedcells. Although the tumours induced by the parental 12B1 cells and 12B1/GM-CSF/cl-5 cells appeared nearly at the same time and then grew at an approximately equal rate, the latter mice were in a much poorer clinical condition. In these animals the growth of the tumours was associated with gradually increasing blood levels of GM-CSF. In both groups of animals splenomegaly was observed; it was much more pronounced in the case of 12B1/GM-CSF/cl-5-inoculated animals. While in the case of an
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NS10634" target="_blank" >NS10634: Chronic myeloid leukemia : immunological studies with mouse and human cells transformed by the bcr-abl fusion gene</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
International Journal of Oncology
ISSN
1019-6439
e-ISSN
—
Volume of the periodical
40
Issue of the periodical within the volume
6
Country of publishing house
GR - GREECE
Number of pages
8
Pages from-to
1915-1922
UT code for WoS article
000303699900021
EID of the result in the Scopus database
—